Launch week offerEnds in00h00m00s

annual Promonthly Pro

Markus L. Lampert

Senior Research Associate, Reader

University of Basel

Switzerland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Switzerland

About

Markus L. Lampert is an Assistant Professor at the University of Basel, Switzerland. His research focuses on pharmacogenetics, particularly in the context of clinical pharmacy, drug interactions, and personalized medicine. Recent publications highlight his work on implementing pharmacist-led pharmacogenetic services and optimizing pain therapy through genetic analysis. He actively engages in developing interprofessional collaboration within healthcare settings to enhance pharmaceutical care.

Articles (14)

Year:

2026

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

Review drafts before you send them.

Markus L. Lampert

Research Interests

Make your next move.

Explore related searches

About

Articles (14)

CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone

P-Glycoprotein–Related Interactions With Paliperidone May Result in Subtherapeutic Drug Levels and Clinical Exacerbation of Schizophrenia

Biomarker‐Based Prediction of OATP1B1 Activity in Clinical Routine—Investigating Coproporphyrins as Markers for Drug–Drug–Gene Interactions

A Clinical Practice Perspective on the Evaluation of <scp>OATP1B1</scp>‐associated Drug Interactions

Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying <i>CYP2D6</i>*4 Variants: A Case Report

Pharmaceutical Discharge Management: Implementation in Swiss Hospitals Compared to International Guidelines

Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B66 and CYP2C1917 variants: a case report

Lessons Learned From Three Months of Pharmaceutical-Care Digital-Education at the University of Basel, Switzerland.

Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?

Collaborators (4)

Samuel Allemann

Kurt E Hersberger

Céline K Stäuble

Henriette E. Meyer zu Schwabedissen

Make your next move.

Markus L. Lampert

Research Interests

Make your next move.

Explore related searches

About

Articles (14)

CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone

P-Glycoprotein–Related Interactions With Paliperidone May Result in Subtherapeutic Drug Levels and Clinical Exacerbation of Schizophrenia

Biomarker‐Based Prediction of OATP1B1 Activity in Clinical Routine—Investigating Coproporphyrins as Markers for Drug–Drug–Gene Interactions

A Clinical Practice Perspective on the Evaluation of <scp>OATP1B1</scp>‐associated Drug Interactions

Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying <i>CYP2D6</i>*4 Variants: A Case Report

Pharmaceutical Discharge Management: Implementation in Swiss Hospitals Compared to International Guidelines

Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B6*6 and CYP2C19*17 variants: a case report

Lessons Learned From Three Months of Pharmaceutical-Care Digital-Education at the University of Basel, Switzerland.

Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?

Collaborators (4)

Samuel Allemann

Kurt E Hersberger

Céline K Stäuble

Henriette E. Meyer zu Schwabedissen

Make your next move.

Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B66 and CYP2C1917 variants: a case report